... and End Results database, a population-based cancer registry that includes approximately 26 percent of ... the researchers identified 1,186 ovarian cancer patients. While most had both ovaries removed, ...
Researchers have discovered that vitronectin receptor expression significantly improved ovarian cancer patient prognosis.
... could be reduced, which would also lower morbidity rates and postoperative complications for ovarian cancer patients. "Our preliminary research indicates that using PET/CT scanning in this way could ...
... "TG2 appears to fuel different types of cancer through multiple molecular pathways, making ... tumor site. More than 70 percent of ovarian cancer patients will suffer a recurrence and eventually succumb ...
... levels of TEM1 were correlated with decreased survival of ovarian cancer patients. Furthermore, all 52 samples ... relative levels of human TEM1 expression in ovarian cancer versus healthy human samples ...
... research that shows obese women have lower ovarian cancer survival rates compared to non- ... disease called epithelial ovarian cancer. Patients were of similar cancer stage and grade, and all had surgery ...
... miRNA and at the miRNA binding sites of 129 cancer-relevant genes. The study examined genetic ... risk, overall survival for ovarian cancer patients, and platinum-based chemotherapy response. Such a wide ...
... in the David H. Koch Institute for Integrative Cancer Research at MIT and a senior author of the paper.
Currently ovarian cancer patients undergo surgery followed by chemotherapy. In many ...
... 15,500, causes more deaths than any other cancer of the female reproductive system. Few effective ... currently is the first line treatment for ovarian cancer patients following surgery. Because Sprycel ...
... overgrowth activity to benefit SGBS patients and the many breast, lung and ovarian cancer patients linked to loss of GPC3,” says Dr. Jorge Filmus, senior scientist, Division of Molecular and ...
... Director of Basic Research at the Moores UCSD Cancer Center, Richard Kolodner, Ph.D., ... cisplatin."
If researchers could track how fast ovarian cancer patients' tumors develop resistance to cisplatin, ...
... , the furthest advanced; evidence of biologic activity has been noted in refractory ovarian cancer patients.
The results set the foundation for additional studies in preparation for using engineered ...
... higher for those with prostate cancer to 61 percent higher for ovarian cancer patients.
The poorer outcome ... D., of Loyola University's Cardinal Bernardin Cancer Center, lead, and senior author of both ...
... is the propensity of tumors to develop resistance to a wide range of anticancer drugs. Over 70 percent of ovarian cancer patients, for example, have drug-resistant tumors at the time ...
... of the relatively rare granulosa cell tumour, which affects five percent of ovarian cancer patients. Using the new sequencing technology and bioinformatics, they discovered a single nucleotide ...
